Background and Aims: The role of COVID-19 regarding in-hospital complications and pour outcomes for patients with ischaemic stroke (IS) is still important to explore. The aim of this study was to evaluate the risk of in-hospital lethality for IS patients respectively to their comorbidities and in-hospital complications in the context of the COVID-19 pandemic. Methods: We identified 1898 acute IS patients (749 men and 1149 women), admitted to Kaunas Hospital of LUHS, Lithuania, from December 2020 to February 2022. The sociodemographic, clinical, and outcome features of the patients were evaluated deploying appropriate statistical tests (Table 1). Hazard ratios and 95% confidence intervals were estimated by the Cox proportional hazards regression for hospital lethality. Results: In men, suffering from IS and comorbid with chronic ischaemic heart disease (cIHD), the risk of in-hospital lethality was 2.22 times higher compared to those, comorbid with isolated arterial hypertension (iAH) (p<0.05). COVID-19 3.16 times elevated the risk of in-hospital lethality in men (p<0.05). In women, comorbid with type 2 diabetes mellitus (DM) or cIHD, the risk of in-hospital lethality was 2 times higher compared to those, with iAH (p<0.05). The risk of in-hospital lethality increased significantly in both men and women, with the total number of in-hospital complications increasing per 1 unit (Table 2). [...]. Conclusions: Of the comorbidities studied, DM and cIHD together with COVID-19, elevated the risk of in-hospital lethality significantly. Within the acute in-hospital complications, pneumonia with respiratory failure and acute renal failure showed the most significant prognostic value anticipating lethal outcomes for IS patients.